Refine Search

New Search

Results: 2

(searched for: doi:10.47419/bjbabs.v2i02.41)
Save to Scifeed
Page of 1
Articles per Page
by
Show export options
  Select all
Zainab Subber, Hashim Hashim, Ghassan Al-Shamma
Baghdad Journal of Biochemistry and Applied Biological Sciences, Volume 2, pp 230-236; https://doi.org/10.47419/bjbabs.v2i04.47

Abstract:
Background: Vitamin D is considered an important regulator of many metabolic processes in the body. Its deficiency was reported to associate with many pathological conditions, with contradicting reports on its role in dyslipidemia. Objectives: To evaluate the role of vitamin D (total and/or free) in improving dyslipidemia of type 2 diabetes mellitus (T2DM). Methods: Sixty-four patients with T2DM, and 73 apparently healthy normal subjects were enrolled in the study from March to October 2020. Their fasting blood glucose, glycated hemoglobin, HbA1c, and serum lipids (cholesterol, its fractions and triglycerides) were measured in addition to total and free vitamin D. Results: There was a significant negative correlation between total vitamin D and each of cholesterol and LDL-C in the diabetic group. The correlations between serum vitamin D and all other lipid parameters (HDL-C, VLDL-C and triglycerides) were non-significant in the diabetic group, while in the control groups none of serum lipids showed significant correlations with vitamin D. Conclusions: The significant negative association of vitamin D with total cholesterol and LDLC in the diabetics reveals the important action of vitamin D in reducing the atherogenic indices, and consequent reduction in the rate of atherosclerosis and cardiovascular disease or stroke.
Page of 1
Articles per Page
by
Show export options
  Select all
Back to Top Top